US Stock MarketDetailed Quotes

CTMX CytomX

Watchlist
  • 1.590
  • -0.010-0.63%
Close Apr 26 16:00 ET
  • 1.590
  • 0.0000.00%
Post 16:05 ET
107.69MMarket Cap-159000P/E (TTM)

About CytomX Company

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.

Company Profile

SymbolCTMX
Company NameCytomX
Listing DateOct 8, 2015
Issue Price12.00
Founded2010
CEODr. Sean A. McCarthy, D.Phil.
MarketNASDAQ
Employees122
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address151 Oyster Point Boulevard,Suite 400
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080-1913
Phone1-605-515-3185
Websitehttp://www.cytomx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Sean A. McCarthy, D.Phil.
  • Chief Executive Officer and Chairman of the Board
  • 2.61M
  • Marcia Belvin
  • Senior Vice President and Chief Scientific Officer
  • 1.21M
  • Lloyd A. Rowland
  • Senior Vice President, General Counsel, Chief Compliance Officer and Secretary
  • 953.39K
  • Jeffrey B. Landau
  • Senior Vice President, Chief Business Officer, and Head of Strategy
  • 1.05M
  • Christopher W. Ogden
  • Senior Vice President, Finance and Accounting, Principal Financial Officer and Principal Accounting Officer
  • --
  • Matthew P. Young
  • Lead Independent Director
  • 105.12K
  • Dr. Alan Ashworth
  • Independent Director
  • 69.12K
  • Dr. Mani Mohindru, PhD
  • Independent Director
  • 78.62K
  • Dr. Elaine V. Jones, PhD
  • Independent Director
  • 75.12K
  • Halley E. Gilbert
  • Independent Director
  • 80.62K
  • James R. Meyers
  • Independent Director
  • 77.12K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg